¼¼°èÀÇ ÀÇ·á¿ë ¹°Æ¼½´ ½ÃÀå
Medicated Wipes
»óǰÄÚµå : 1793027
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 375 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,186,000
PDF & Excel (Single User License) help
PDF & Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÆÄÀÏ ³» ÅØ½ºÆ®ÀÇ º¹»ç ¹× ºÙ¿©³Ö±â´Â °¡´ÉÇÏÁö¸¸, Ç¥/±×·¡ÇÁ µîÀº º¹»çÇÒ ¼ö ¾ø½À´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,559,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ¹× 100% ÀÚȸ»çÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1Àδç 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ÀÇ·á¿ë ¹°Æ¼½´ ½ÃÀåÀº 2030³â±îÁö 114¾ï ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 84¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ÀÇ·á¿ë ¹°Æ¼½´ ¼¼°è ½ÃÀåÀº 2024-2030³â°£ CAGR 5.3%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 114¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀΠâ»ó°ü¸® Á¦Ç°Àº CAGR 4.6%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 54¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Ä¡Áú Äɾî Á¦Ç° ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£Áß CAGR 7.2%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 23¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 8.3%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ÀÇ·á¿ë ¹°Æ¼½´ ½ÃÀåÀº 2024³â¿¡ 23¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2024-2030³âÀÇ ºÐ¼® ±â°£¿¡ CAGR 8.3%·Î ¼ºÀåÀ» Áö¼ÓÇÏ¿©, 2030³â¿¡´Â ½ÃÀå ±Ô¸ð°¡ 23¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 2.6%¿Í 5.2%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 3.4%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ ÀÇ·á¿ë ¹°Æ¼½´ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

ÀÇ·á¿ë ¹°Æ¼½´°¡ ÀÏ»óÀûÀÎ À§»ý ¹× °Ç°­ °ü¸®¿¡ ÇʼöÀûÀÎ Á¸Àç°¡ µÇ°í ÀÖ´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

ÀÇ·á¿ë ¹°Æ¼½´´Â °³ÀÎ À§»ý ¹× ÀÓ»ó À§»ýÀÇ Áß¿äÇÑ ¿ä¼Ò·Î ÁøÈ­ÇÏ¿© ¼¼Ã´, ¼Òµ¶ ¹× ƯÁ¤ ÇǺΠ»óÅÂÀÇ Ä¡·á¿¡ Æí¸®Çϰí È¿°úÀûÀÎ ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù. ÀÏ¹Ý ¹°Æ¼½´¿Í ´Þ¸® ÀÇ·á¿ë ¹°Æ¼½´¿¡´Â Ŭ·Î¸£Çí½Ãµò, »ì¸®½Ç»ê, ¿°È­º¥ÀßÄÚ´½, ¸¶³à °³¾Ï µî ÀǾà Ȱ¼º ¼ººÐÀÌ ÇÔÀ¯µÇ¾î ÀÖ¾î ¼Òµ¶, Ç׿°Áõ, Ç×Áø±Õ, Ç×±Õ µîÀÇ È¿°ú°¡ ÀÖ½À´Ï´Ù. º´¿ø, ¿Ü·¡ Áø·á¼Ò, ÀçÅà ġ·á ÇöÀå¿¡¼­ °¨¿° ¿¹¹æ, ÇǺΠ¿°Áõ °ü¸®, »óó °ü¸® Áö¿ø¿¡ ³Î¸® »ç¿ëµË´Ï´Ù. ¼ÒºñÀÚµéÀº ¿Ü¿ë Å©¸²À̳ª ·Î¼ÇÀ» ´ëüÇÒ ¼ö ÀÖ´Â ½Ç¿ëÀûÀÎ ´ë¾ÈÀ¸·Î, ƯÈ÷ ¼ÕÀÌ Àß ´êÁö ¾Ê´Â ºÎÀ§³ª ¹Î°¨ÇÑ ºÎÀ§¿¡ »ç¿ëÇÏ´Â °æ¿ì°¡ ´Ã°í ÀÖ½À´Ï´Ù. Àαâ Ä«Å×°í¸®¿¡´Â ¿©µå¸§ Ä¡·á¿ë ¹°Æ¼½´, ¿©¼º¿ë ¹°Æ¼½´, ¾Æ±â¿ë ¹°Æ¼½´, ¿ä½Ç±Ý °ü¸®¿ë ¹°Æ¼½´ µî ´Ù¾çÇÑ Ä«Å×°í¸®°¡ ÀÖÀ¸¸ç, °¢ Ä«Å×°í¸®´Â ƯÁ¤ ÇǺΰúÀû ¿ä±¸¿Í À§»ýÀû Çʿ並 ÃæÁ·Çϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù. ȯ°æ¿À¿°, ÀæÀº ¼Õ¾Ä±â, ÀÚ±ØÀûÀÎ ¼¼Á¤Á¦·Î ÀÎÇÑ ÇǺΠ°ú¹ÎÁõ Áõ°¡·Î ÀÎÇØ º¸´Ù ¼øÇϰí È¿°úÀûÀÎ ÀÇ·á¿ë ó¹æÀÇ Ã¤ÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ ¹°Æ¼½´´Â È޴뼺, Á¤È®ÇÑ ¿ë·®, À§»ýÀûÀÎ 1ȸ¿ë »ç¿ëÀ¸·Î À̵¿ÀÌ ÀæÀº ¶óÀÌÇÁ ½ºÅ¸Àϰú ¿©Çà¿¡ ÀÌ»óÀûÀÔ´Ï´Ù. ¶ÇÇÑ, ¼ö¼ú ÈÄ °ü¸®³ª ¹° ¼¼Ã´ÀÌ ½Ç¿ëÀûÀÌÁö ¾ÊÀº °Åµ¿ÀÌ ºÒÆíÇÑ È¯Àڵ鿡°Ô ƯÈ÷ À¯¿ëÇÏ°Ô »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ¼ÒºñÀÚ¿Í ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü°¡ °¨¿° ¿¹¹æ, ÇǺΠ¹«°á¼º ¹× À§»ý À¯Áö¿¡ ´õ ¸¹Àº °ü½ÉÀ» ±â¿ïÀ̸鼭 ÀÇ·á¿ë ¹°Æ¼½´´Â ÀÓ»ó ¹× ºñÀÓ»ó ȯ°æ ¸ðµÎ¿¡¼­ º¸Á¶ Á¦Ç°¿¡¼­ ÀÏ»ó ÇʼöǰÀ¸·Î ÀüȯµÇ°í ÀÖ½À´Ï´Ù.

ÀÇ·á¿ë ¹°Æ¼½´ÀÇ ¸Å·ÂÀº Á¦Ç°ÀÇ Çõ½Å°ú ¼ººÐÀÇ ¹ßÀüÀ¸·Î ¾î¶»°Ô È®´ëµÇ°í Àִ°¡?

ÀÇ·á¿ë ¹°Æ¼½´ ½ÃÀåÀº º¸´Ù Àü¹®ÀûÀÌ°í ¾ÈÀüÇϸç ģȯ°æÀûÀÎ Á¦Ç°À» ¿øÇÏ´Â ¼ÒºñÀÚÀÇ ¿ä±¸¿¡ µû¶ó Å« Çõ½ÅÀ» °æÇèÇϰí ÀÖ½À´Ï´Ù. ½ÅÁ¦Ç° °³¹ßÀº Ç×±Õ È¿°ú´Â À¯ÁöÇϸ鼭 ÀÚ±ØÀ» ÁÙ¿©ÁÖ´Â ÀúÀÚ±Ø, ¹«¾ËÄÚ¿Ã, ¹«Çâ ó¹æ µî ÇǺΠ¹Î°¨¼º¿¡ ÃÊÁ¡À» ¸ÂÃá Á¦Ç°µéÀÌ ´Ã¾î³ª°í ÀÖ½À´Ï´Ù. ¾Ë·Î¿¡º£¶ó, Ä«¸ð¸¶ÀÏ, ƼƮ¸® ¿ÀÀÏ, Ä«·»µâ¶ó µî õ¿¬ ¼ººÐÀ» ÇÔÀ¯ÇØ ±âÁ¸ÀÇ È­ÇÐ ¹æºÎÁ¦¸¦ ´ëüÇÒ ½Ä¹°¼º ¹æºÎÁ¦¸¦ ã´Â ¼ÒºñÀڵ鿡°Ô ¾îÇÊÇϰí ÀÖ½À´Ï´Ù. ¿ø´Ü ±â¼úÀÇ ¹ßÀüµµ Á¦Ç° ¼º´É Çâ»ó¿¡ ±â¿©Çϰí ÀÖÀ¸¸ç, ´õ ºÎµå·´°í ³»±¸¼ºÀÌ ¶Ù¾î³­ ¼ÒÀç°¡ ´õ ¿ì¼öÇÑ Èí¼ö¼º°ú ÇǺΠ¸¶ÂûÀ» ÃÖ¼ÒÈ­Çϰí ÀÖ½À´Ï´Ù. ¿À´Ã³¯¿¡´Â ÀÇ·á¿ë ¶Ç´Â ±î´Ù·Î¿î ÇǺΠ»óŸ¦ À§ÇØ ¼¼Ã´ È¿À²À» ³ôÀ̱â À§ÇØ ¼³°èµÈ ´ÙÃþ ¶Ç´Â Áú°¨ÀÌ Àִ ǥ¸éÀ» °¡Áø ¹°Æ¼½´µµ ÀÖ½À´Ï´Ù. ¼Ò¾Æ ¹× ³ëÀÎ Äɾ¼­´Â »êÈ­¾Æ¿¬, µð¸ÞƼÄÜ µî ÇǺΠÀ庮 º¸È£Á¦°¡ ÇÔÀ¯µÈ ¹°Æ¼½´°¡ ÁøÁ¤ ¹× º¸È£ ÀÛ¿ëÀ¸·Î Àα⸦ ²ø°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Áö¼Ó °¡´ÉÇÑ À§»ý ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ¼±È£µµ°¡ ³ô¾ÆÁü¿¡ µû¶ó »ýºÐÇØ¼º, ¹°¿¡ Èê·Áº¸³¾ ¼ö ÀÖ´Â À¯Çüµµ º¸±ÞµÇ°í ÀÖ½À´Ï´Ù. ÀÓ»ó ºÐ¾ß¿¡¼­´Â ÇÇºÎ¿Í Ç¥¸éÀ» ¸ðµÎ ¼Òµ¶ÇÏ´Â ³ôÀº ¼öÁØÀÇ ¼Òµ¶¿ë ¹°Æ¼½´°¡ °³¹ßµÇ¾î º´¿ø, ±¸±ÞÂ÷, ¿ä¾ç½Ã¼³ÀÇ °¨¿° °ü¸®¸¦ Áö¿øÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÏȸ¿ë ÀÏȸ¿ë ¹°Æ¼½´´Â ¿©Çà¿ë ÆÑ, °øÁß º¸°Ç¼Ò, ¼Ò¸ÅÁ¡ µî¿¡¼­ ÈçÈ÷ º¼ ¼ö ÀÖ´Â Æí¸®ÇÑ °³º° Æ÷Àå ¹°Æ¼½´ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº ¾ÈÀü, Æí¾ÈÇÔ, ȯ°æÀû Ã¥ÀÓ°¨À» ÈѼÕÇÏÁö ¾ÊÀ¸¸é¼­µµ ¼ÒºñÀÚÀÇ Æø³ÐÀº ¿ä±¸¸¦ ÃæÁ·½Ãų ¼ö ÀÖ´Â ¸ÂÃãÇü °í¼º´É À§»ý¿ëǰ¿¡ ´ëÇÑ ±¤¹üÀ§ÇÑ Æ®·»µå¸¦ ¹Ý¿µÇϰí ÀÖ½À´Ï´Ù.

°Ç°­ °ü¸®¿Í ¼ÒºñÀÚ È¯°æÀÇ Â÷ÀÌ´Â ¾î¶»°Ô ÀÇ·á¿ë ¹°Æ¼½´ ¼ö¿ä¸¦ ÃËÁøÇմϱî?

ÀÇ·á¿ë ¹°Æ¼½´¿¡ ´ëÇÑ ¼ö¿ä´Â ÀÇ·á ȯ°æ, ¼ÒºñÀÚÃþ, Áö¿ª¸¶´Ù Å©°Ô ´Ù¸£¸ç, Á¢±Ù¼º, ±³À°, À§»ý ½À°üÀÇ Â÷À̸¦ ¹Ý¿µÇÕ´Ï´Ù. º´¿ø ¹× ÀÓ»ó ȯ°æ¿¡¼­ ¼Òµ¶ ¹°Æ¼½´´Â Áֻ縦 À§ÇÑ ÇǺΠÁغñ, »óó ¼¼Ã´, ȯÀÚ¿Í Ç¥¸é »çÀÌÀÇ ÀÌÂ÷ ¿À¿°À» ¹æÁöÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. ÀÌ·¯ÇÑ ¹°Æ¼½´ Á¦Ç°Àº ¾ö°ÝÇÑ ±ÔÁ¦ ±âÁØÀ» ÃæÁ·ÇØ¾ß Çϸç, ¾ÈÀü¼º°ú À¯È¿¼ºÀ» º¸ÀåÇϱâ À§ÇØ º´¿ø±Þ ¼Òµ¶Á¦¸¦ »ç¿ëÇÏ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ³ëÀÎ ½Ã¼³°ú Àå±â ¿ä¾ç ½Ã¼³¿¡¼­ ÀÇ·á¿ë ¹°Æ¼½´´Â ¿ä½Ç±Ý °ü¸®, ¿åâ ¿¹¹æ, °Åµ¿ÀÌ ºÒÆíÇÑ È¯ÀÚÀÇ °³ÀÎ À§»ý À¯Áö¿¡ ÇʼöÀûÀÎ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. °£º´ÀÎÀ̳ª °¡Á¤ »ç¿ëÀÚ, ƯÈ÷ ¿µÀ¯¾Æ ¹× ¼ö¼ú ÈÄ °ü¸®, ÇǺΰú Ä¡·á ·çƾ¿¡¼­ ±âÁ¸ÀÇ ¼¼Ã´ ¹æ¹ý¿¡ ´ëÇÑ ¾ó·èÀÌ ¾ø°í È¿À²ÀûÀÎ ´ë¾ÈÀ» Á¦°øÇÕ´Ï´Ù. ÀÏ¹Ý ¼ÒºñÀÚµé »çÀÌ¿¡¼­ »ì¸®½Ç»ê°ú °ú»êÈ­º¥Á¶ÀÏ ¼ººÐÀÌ ÇÔÀ¯µÈ ¼¼¾È¿ë ¹°Æ¼½´´Â ¿©µå¸§ Ä¡·á¿¡ ³Î¸® »ç¿ëµÇ°í ÀÖÀ¸¸ç, ƯÈ÷ Æí¸®ÇÑ ÇǺΠ°ü¸® ¼Ö·ç¼ÇÀ» ¿øÇϴ û¼Ò³â°ú ÀþÀº Ãþ¿¡°Ô ÀαⰡ ÀÖ½À´Ï´Ù. pH ±ÕÇü°ú ³¿»õ Á¶ÀýÀ» À§ÇØ ¼³°èµÈ ¿©¼º¿ë À§»ý ¹°Æ¼½´´Â ¿©¼ºµé »çÀÌ¿¡¼­ ÀαⰡ ÀÖÀ¸¸ç, ¶¡°ú ¹ÚÅ׸®¾Æ¸¦ °Ü³ÉÇÑ ³²¼º¿ë ±×·ç¹Ö ¹°Æ¼½´µµ ½ÃÀå¿¡¼­ ÀÔÁö¸¦ ³ÐÇô°¡°í ÀÖ½À´Ï´Ù. ¿©ÇàÀ̳ª Ä·ÇÎ, ¿ÜÃ⠽à ÀÇ·á¿ë ¹°Æ¼½´´Â È޴뼺ÀÌ ¶Ù¾î³ª ¹°À» ±¸Çϱ⠾î·Á¿î °÷¿¡¼­µµ À§»ýÀ» À¯ÁöÇÒ ¼ö ÀÖ´Ù´Â Á¡¿¡¼­ ³ôÀº Æò°¡¸¦ ¹Þ°í ÀÖ½À´Ï´Ù. Áö¿ªÀûÀ¸·Î´Â ±ú²ýÇÑ ¹°¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ Á¦ÇÑµÈ Áö¿ªÀ̳ª °øÁߺ¸°Ç Ä·ÆäÀÎÀ¸·Î Àü¿°º´ ¿¹¹æ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁø Áö¿ª¿¡¼­ ¼ö¿ä°¡ ±ÞÁõÇÕ´Ï´Ù. ÀÌ ¸ðµç »óȲ¿¡¼­ ÁÖ¿ä ¿øµ¿·ÂÀº ÆíÀǼº, È¿À²¼º, ±×¸®°í ƯÁ¤ ÀÌ¿ë »ç·Ê¿Í »óȲ¿¡ ¸Â´Â ¸ÂÃãÇü À§»ý ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡Çϰí ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù.

Àü ¼¼°èÀûÀ¸·Î ÀÇ·á¿ë ¹°Æ¼½´ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀº?

ÀÇ·á¿ë ¹°Æ¼½´ ½ÃÀåÀÇ ¼ºÀåÀº °Ç°­ ÀνÄ, Àα¸ Åë°è ÇÐÀû º¯È­, ±â¼ú ¹ßÀü, ¶óÀÌÇÁ ½ºÅ¸ÀÏ º¯È­ÀÇ Á¶ÇÕÀ¸·Î ÀÎÇØ ¹ß»ýÇÕ´Ï´Ù. ù°, ƯÈ÷ Àü¿°º´ ¹× ÀÇ·á °ü·Ã °¨¿°À» °è±â·Î °¨¿° ¿¹¹æ ¹× À§»ý À¯Áö¿¡ ´ëÇÑ Àü ¼¼°èÀÇ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ÀÏȸ¿ë ¼Òµ¶ ¹°Æ¼½´°¡ °¡Á¤°ú ÀÇ·á½Ã¼³ÀÇ ÇʼöǰÀ¸·Î ÀÚ¸® Àâ¾Ò½À´Ï´Ù. µÑ°, ¿©µå¸§, ÇǺο°, °õÆÎÀÌ °¨¿°, ¹Î°¨¼º ÇǺΠµî ÇǺΠÁúȯ Áõ°¡·Î ÀÎÇØ ¼ÒºñÀÚµéÀº ÃÖ¼ÒÇÑÀÇ ³ë·ÂÀ¸·Î Ç¥Àû Ä¡·á°¡ °¡´ÉÇÑ »ç¿ëÇϱ⠽¬¿î ¿Ü¿ë ¼Ö·ç¼ÇÀ» ¿øÇϰí ÀÖ½À´Ï´Ù. ¼Â°, ½ÅÈï ½ÃÀåÀÇ ÇコÄɾî ÀÎÇÁ¶ó°¡ È®´ëµÇ°í ½ÃÆÇµÇ´Â ÇǺΰú Á¦Ç°¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ Çâ»óµÊ¿¡ µû¶ó ¼ÒºñÀÚµéÀº ´õ ¸¹Àº Á¦Ç°À» Á¢ÇÒ ¼ö ÀÖ´Â ±âȸ°¡ ¸¹¾ÆÁ³°í, Á¦Ç° Á¢±Ù¼ºÀÌ ³ô¾ÆÁ³½À´Ï´Ù. ³Ý°, ¸¹Àº ±¹°¡¿¡¼­ Àα¸ °í·ÉÈ­°¡ ÁøÇàµÊ¿¡ µû¶ó ³ëÀÎ À§»ý º¸Á¶Á¦, ƯÈ÷ ¼¼Á¤ ¹× ÇǺΠº¸È£ ±â´ÉÀ» ¸ðµÎ Á¦°øÇÏ´Â Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ´Ù¼¸Â°, ¼ÒºñÀÚÀÇ ÃëÇâÀÌ ºü¸£°Ô º¯È­ÇÏ´Â ¶óÀÌÇÁ½ºÅ¸ÀÏ¿¡ ¸ÂÃß¾î ÈÞ´ë°¡ °£ÆíÇÏ°í ºü¸£°Ô »ç¿ëÇÒ ¼ö ÀÖ´Â Á¦Ç°À¸·Î ÁøÈ­Çϰí ÀÖÀ¸¸ç, À§»ý°ú Ä¡·áÀÇ ÀåÁ¡À» ¸ðµÎ °®Ãá ¹°Æ¼½´¿¡ ´ëÇÑ ¼ö¿ëÀûÀÎ ½ÃÀåÀÌ Çü¼ºµÇ°í ÀÖ½À´Ï´Ù. ¿©¼¸Â°, Áö¼Ó °¡´ÉÇÑ Àç·á¿Í ´õ ±ú²ýÇÑ Æ÷¹Ä·¯ÀÇ Çõ½ÅÀº ȯ°æ ģȭÀû ÀÎ ±¸¸ÅÀÚ¸¦ ²ø¾î µéÀ̰í ȯ°æ ģȭÀû ÀÎ »îÀ» ¿ì¼±½ÃÇÏ´Â »ç¿ëÀڵ鿡°Ôµµ ÀÇ·á¿ë ¹°Æ¼½´ÀÇ ¸Å·ÂÀ» ³ÐÈ÷°í ÀÖ½À´Ï´Ù. Àϰö°, ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü, ¾à±¹, ¼Ò¸Å üÀÎ °£ÀÇ ÆÄÆ®³Ê½ÊÀÌ È®´ëµÇ¸é¼­ À¯Åë ä³ÎÀÌ È®´ëµÇ°í ÀÎÁöµµ°¡ ³ô¾ÆÁ³½À´Ï´Ù. ¸¶Áö¸·À¸·Î, ÀüÀÚ»ó°Å·¡ Ç÷§ÆûÀº º¸´Ù Á÷Á¢ÀûÀÌ°í ±³À°ÀûÀÎ ¸¶ÄÉÆÃ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ ¼ÒºñÀÚ°¡ ÀÇ·á¿ë ¹°Æ¼½´ÀÇ ÀÌÁ¡À» ÀÌÇØÇÏ°í °³º° ¿ä±¸¿¡ ¸Â´Â Á¦Ç°À» ¼±ÅÃÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÃËÁø¿äÀÎÀÌ °áÇյǾî ÀÇ·á¿ë ¹°Æ¼½´´Â °Ç°­ °ü¸®, ½ºÅ² ÄÉ¾î ¹× ÆíÀǼºÀÇ ±³Â÷Á¡¿¡ À§Ä¡ÇÑ ¿ªµ¿ÀûÀÌ°í ºü¸£°Ô ¼ºÀåÇÏ´Â ¼¼°è ½ÃÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Ç°(â»ó°ü¸® Á¦Ç°, Ä¡Áú Äɾî Á¦Ç°, ÇǺΠÄɾî Á¦Ç°, Æä¹Ì´Ñ Äɾî Á¦Ç°, ±âŸ Á¦Ç°), °ø±Þ¿ø(µå¶óÀÌ ¹°Æ¼½´, ¿þÆ® ¹°Æ¼½´), À¯Åë ä³Î(¼Ò¸Å ¾à±¹, º´¿ø ¾à±¹, ¿Â¶óÀÎ À¯Åë ä³Î)

Á¶»ç ´ë»ó ±â¾÷ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ¼­, ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇÕ´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°èº° SLM Äõ¸®¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Medicated Wipes Market to Reach US$11.4 Billion by 2030

The global market for Medicated Wipes estimated at US$8.4 Billion in the year 2024, is expected to reach US$11.4 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2024-2030. Wound Care Products, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$5.4 Billion by the end of the analysis period. Growth in the Hemorrhoid Care Products segment is estimated at 7.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.3 Billion While China is Forecast to Grow at 8.3% CAGR

The Medicated Wipes market in the U.S. is estimated at US$2.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.3 Billion by the year 2030 trailing a CAGR of 8.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.6% and 5.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Global Medicated Wipes Market - Key Trends & Drivers Summarized

Why Are Medicated Wipes Becoming Essential in Everyday Hygiene and Healthcare Routines?

Medicated wipes have evolved into a critical component of both personal and clinical hygiene, offering a convenient and effective solution for cleansing, disinfecting, and treating specific skin conditions. Unlike standard wet wipes, medicated wipes are infused with active pharmaceutical ingredients such as chlorhexidine, salicylic acid, benzalkonium chloride, or witch hazel, which provide antiseptic, anti-inflammatory, antifungal, or antibacterial benefits. They are widely used in hospitals, outpatient clinics, and home care settings to prevent infections, manage skin irritations, and support wound care. Consumers increasingly use them as a practical alternative to topical creams and lotions, especially for hard-to-reach or sensitive areas. Popular categories include acne treatment wipes, feminine hygiene wipes, baby care wipes, and incontinence care wipes, each designed to address specific dermatological or hygiene needs. The rise in skin sensitivities caused by environmental pollution, frequent handwashing, and harsh cleansing agents has also driven the adoption of gentler yet effective medicated formulations. These wipes offer portability, precise dosing, and hygienic single-use application, making them ideal for on-the-go lifestyles and travel. Furthermore, they are especially valued in post-operative care and for patients with limited mobility, where water-based cleansing may not be practical. As consumers and healthcare providers place greater emphasis on infection prevention, skin integrity, and hygiene maintenance, medicated wipes are transitioning from supplementary products to everyday essentials in both clinical and non-clinical environments.

How Are Product Innovations and Ingredient Advancements Expanding the Appeal of Medicated Wipes?

The medicated wipes market is experiencing significant innovation driven by consumer demand for more specialized, safe, and eco-friendly products. New product developments are increasingly focusing on skin sensitivity, with hypoallergenic, alcohol-free, and fragrance-free formulations that reduce irritation while maintaining antimicrobial efficacy. Natural ingredients like aloe vera, chamomile, tea tree oil, and calendula are being incorporated to appeal to consumers seeking plant-based alternatives to traditional chemical antiseptics. Advances in fabric technology are also contributing to enhanced product performance, with softer, more durable materials that ensure better absorption and minimal friction against the skin. Some wipes now include multi-layered or textured surfaces designed to improve cleansing efficiency for medical use or difficult skin conditions. In pediatric and elderly care, wipes infused with skin barrier-protecting agents such as zinc oxide or dimethicone are gaining traction for their soothing and protective properties. Biodegradable and flushable options are also becoming more prevalent, aligning with the growing consumer preference for sustainable hygiene solutions. In the clinical space, high-level disinfectant wipes are being developed to sanitize both skin and surfaces, supporting infection control in hospitals, ambulances, and nursing homes. Additionally, individually wrapped wipes for single-use convenience are now common in travel packs, public hygiene stations, and retail formats. These innovations reflect the broader trend toward targeted, high-performance hygiene products that meet a wide range of consumer needs without compromising safety, comfort, or environmental responsibility.

How Do Different Healthcare and Consumer Environments Drive Demand for Medicated Wipes?

The demand for medicated wipes varies significantly across healthcare settings, consumer demographics, and geographic regions, reflecting differences in access, education, and hygiene practices. In hospitals and clinical environments, antiseptic wipes are used to prepare skin for injections, cleanse wounds, and prevent cross-contamination between patients and surfaces. These wipes must meet strict regulatory standards and often feature hospital-grade disinfectants to ensure safety and effectiveness. In elderly and long-term care facilities, medicated wipes play an essential role in managing incontinence, preventing pressure ulcers, and maintaining personal hygiene in patients with limited mobility. For caregivers and home users, wipes provide a mess-free, efficient alternative to traditional washing methods, particularly for infants, post-surgical care, or dermatological treatment routines. Among general consumers, facial wipes with salicylic acid or benzoyl peroxide are widely used for acne treatment, especially by adolescents and young adults seeking convenient skincare solutions. Feminine hygiene wipes designed for pH balance and odor control are popular among women, while men’s grooming wipes targeting sweat and bacteria are also gaining market presence. In travel, camping, and on-the-go scenarios, medicated wipes are valued for their portability and ability to maintain hygiene when water is not readily available. Regionally, demand spikes in areas with limited access to clean water or where awareness of infection control is increasing due to public health campaigns. In all of these contexts, the primary drivers are convenience, efficacy, and the growing need for personalized hygiene solutions tailored to specific use cases and conditions.

What Key Factors Are Driving the Growth of the Medicated Wipes Market Globally?

The growth in the medicated wipes market is driven by a combination of health consciousness, demographic shifts, technological advancement, and lifestyle changes. First, the increasing global focus on infection prevention and hygiene maintenance, especially in the wake of pandemics and healthcare-associated infections, has made disposable disinfectant wipes a staple in households and medical facilities. Second, rising rates of skin conditions such as acne, dermatitis, fungal infections, and sensitive skin are prompting consumers to seek easy-to-use, topical solutions that deliver targeted treatment with minimal effort. Third, the expansion of healthcare infrastructure and better access to over-the-counter dermatological products in emerging markets is increasing consumer exposure and product availability. Fourth, aging populations in many countries are driving demand for hygiene aids in elderly care, particularly products that offer both cleansing and skin protection. Fifth, consumer preferences are evolving toward portable, quick-use products that align with fast-paced lifestyles, creating a receptive market for wipes that combine hygiene and therapeutic benefits. Sixth, innovations in sustainable materials and cleaner formulations are attracting environmentally conscious buyers, broadening the appeal of medicated wipes to include users who prioritize green living. Seventh, growing partnerships between healthcare providers, pharmacies, and retail chains are expanding distribution channels and enhancing visibility. Lastly, e-commerce platforms are enabling a more direct and educational marketing approach, helping consumers understand the benefits of medicated wipes and choose products suited to their individual needs. Collectively, these drivers are contributing to a dynamic and rapidly expanding global market that positions medicated wipes at the intersection of healthcare, skincare, and convenience.

SCOPE OF STUDY:

The report analyzes the Medicated Wipes market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Wound Care Products, Hemorrhoid Care Products, Dermatological Care Products, Feminine Care Products, Other Products); Source (Dry Wipes, Wet Wipes); Distribution Channel (Retail Pharmacies, Hospital Pharmacies, online distribution channel)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 39 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â